Upside sharing arrangement settled - INR 1,276.83 million paid to founders

Business Updates View source PDF Explain this filing

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.4%Reaction day

₹957.50

prior close

₹957.70

announcement price

After-mkt

timing

Nifty Midcap 150market-0.4%-1.0% vs market

Biotechnology peers, median of 5sector+0.0%-1.4% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Midcap 150 and 1.4 pts less than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+1.2

15m

+1.9

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.4-0.4-1.0+0.0-1.4

Next day

-2.3-0.8-1.5+1.7-4.0

-1.8-1.0-0.7-1.2-0.5

-1.3-3.2+1.9-2.4+1.1

-4.6-3.1-1.5-3.4-1.2

-3.0-2.3-0.7-2.5-0.5

-4.0-1.2-2.8-3.6-0.3

15d

-10.3-6.3-4.1-7.6-2.7

-9.6-6.4-3.1-9.6+0.0

—————

UpDownMarket · Nifty Midcap 150Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anthem Biosciences has settled an upside sharing arrangement linked to a prior divestment by Viridity Tone LLP. About INR 1,276.83 million has been paid to three Upside Principal Shareholders (Ajay Bhardwaj, Ganesh Sambasivam, K. Ravindra Chandrappa), following public shareholder approval at the July 22, 2026 AGM.

Likely market impact

Likely neutral. A pre-approved cash outflow of about INR 1,276.83 million to three promoter/founder shareholders to close an existing obligation.